Kishida Y, Shingai N, Hara K, Yomota M, Kato C, Sakai S, Kambara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakashima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Toya T, Shimizu H, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N.

Impact of lung function impairment after allogeneic hematopoietic stem cell transplantation.

Sci Rep 19;12(1):14155,2022.doi: 10.1038/s41598-022-18553-6.

https://pubmed.ncbi.nlm.nih.gov/35986078/

Tokai T, Takashio S, Kawano Y, Kidoh M, Oda S, Matsuoka M, Tsujita K.

Assessing the treatment effect of daratumumab by serial measurements of cardiac biomarkers and imaging parameters in light-chain cardiac amyloidosis.

J Cardiol Cases 16;26(4):301-304,2022.doi: 10.1016/j.jccase.2022.06.008.

https://pubmed.ncbi.nlm.nih.gov/36187319/

Mitsuhiro Uchiba, Masao Matsuoka.

Using weighted harmonic mean for prediction of APTT in the mixing test.

Thrombosis Update.

Volume 8, August 2022, 100114.

https://www.sciencedirect.com/science/article/pii/S2666572722000189?via%3Dihub

Masuda T, Inamori Y, Furukawa A, Yamahiro M, Momosaki K, Chang CH, Kobayashi D, Ohguchi H,Kawano Y, Ito S, Araki N, Ong SE, Ohtsuki S.

Water droplet-in-oil digestion method for single-cell proteomics.

Anal Chem 26;94(29):10329-10336,2022.doi: 10.1021/acs.analchem.1c05487.

https://pubmed.ncbi.nlm.nih.gov/35817413/

Tamanoi D, Saruwatari K, Imamura K, Sato R, Jodai T, Hamada S, Tomita Y, Saeki S, Ueno S, Yonemura Y, Ichiyasu H, Sakagami T.

case of pembrolizumab-related immune thrombocytopenia in a patient with lung adenocarcinoma treated by radiotherapy: potential immune-related adverse event elicited by radiation therapy.

Internal Med 61(11):1731-1734,2022. doi: 10.2169/internalmedicine.

https://pubmed.ncbi.nlm.nih.gov/34776479/

Yano H, Fujiwara Y, Horlad H, Pan C, Kai K, Niino D, Ohsawa K, Higashi M, Nosaka K, Okuno Y, Tamaru JI, Mukasa A, Matsuoka M, Komohara Y.

Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.

https://pubmed.ncbi.nlm.nih.gov/35343027/

Shichijo T, Nosaka K, Tatetsu H, Higuchi Y, Endo S, Inoue Y, Toyoda K, Kikukawa Y, Kawakita T, Yasunaga JI, Matsuoka M.

Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma.

Br J Haematol 198(6):983-987,2022.doi: 10.1111/bjh.18281. 

https://pubmed.ncbi.nlm.nih.gov/35607839/

Kim K, Min CK, Koh Y, Ishizawa K, Kim SH, Ito S, Tanaka J, Uchiyama M, Kawano Y, Kim JS, Moreau P, Martin T, Dong Y, Risse ML, Suzuki K.

Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.

Int J Hematol 116(4):553-562,2022.doi: 10.1007/s12185-022-03378-w.

https://pubmed.ncbi.nlm.nih.gov/35578151/

Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M.

Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma

Br J Haematol ,2022. doi: 10.1111/bjh.18234. Online ahead of print.

https://pubmed.ncbi.nlm.nih.gov/35524546/

Ghosh AK, Kovela S, Sharma A, Shahabi D, Ghosh AK, Hopkins DR, Yadav M, Johnson ME, Agniswamy J, Wang YF, Hattori SI, Higashi-Kuwata N, Aoki M, Amano M, Weber IT, Mitsuya H.

Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands.

ChemMedChem doi: 10.1002/cmdc.202200058,2022.  doi: 10.1002/cmdc.202200058.

https://pubmed.ncbi.nlm.nih.gov/35170223/

Matsuo M, Ueno T, Monde K, Sugata K, Tan BJY, Rahman A, Miyazato P, Uchiyama K, Islam S, Katsuya H, Nakajima S, Tokunaga M, Nosaka K, Hata H, Utsunomiya A, Fujisawa JI, Satou Y.

Identification and characterization of a novel enhancer in the HTLV-1 proviral genome.

Rajib S.A, Ogi Y, Hossain M.B, Ikeda T, Tanaka E, Kawaguchi T, Satou Y.

A SARS-CoV-2 Delta variant containing mutation in the probe binding regions used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result.

J Infect Chemother 28(5):669-677,2022. doi: 10.1016/j.jiac.2022.01.019

https://pubmed.ncbi.nlm.nih.gov/35144878/

Oka K, Matsumoto A, Tetsuka N, Morioka H, Iguchi M, Ishiguro N, Nagamori T, Takahashi S, Saito N, Tokuda K, Igari H, Fujikura Y, Kato H, Kanai S, Kusama F, Iwasaki H, Furuhashi K, Baba H, Nagao M, Nakanishi M, Kasahara K, Kakeya H, Chikumi H, Ohge H, Azuma M, Tauchi H, Shimono N, Hamada Y, Takajo I, Nakata H, Kawamura H, Fujita J.

apan Infection Prevention and Control Conference for National and Public University Hospitals. Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan.

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.

Two-year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia.

Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiyama H, Shimono A, Yonemura Y, Kawaguch T, Chiba S, Kanakura Y, Nishimura J, Ninomiya H, Obara N.

Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab:post-marketing surveillance in Japan.

Int J Hematol 115(4):470-480,2022. doi: 10.1007/s12185-022-03287-y.

https://pubmed.ncbi.nlm.nih.gov/35146630/

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.

Two-year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia.

Cancer Sci online ahead of print (DOI:10.1111/cas.15344)

https://pubmed.ncbi.nlm.nih.gov/35332633/

Marumo A, Omori I, Tara S, Otsuka Y, Konuma R, Adachi H, Wada A, Kishida Y, Konishi T, Nagata A, Yamada Y, Nagata R, Noguchi Y, Toya T, Igarashi A, Najima Y, Kobayashi T, Yamaguchi H, Inokuchi K, Sakamaki H, Ohashi K, Doki N.

Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less.

Inoue Y, Nishimura N, Murai M, Matsumoto M, Watanabe M, Yamada A, Izaki M, Nosaka K, Matsuoka M.

Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.

Int J Hematol 115(3):435-9,2022.  doi: 10.1007/s12185-021-03250-3.

https://pubmed.ncbi.nlm.nih.gov/34705226/

Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y, Tatetsu H, Nawa Y, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R.

Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study.

Int J Hematol 115(3):382-390,2022. doi: 10.1007/s12185-021-03281-w.

https://pubmed.ncbi.nlm.nih.gov/34981434/

Nosaka K, Crawford B, Yi J, Kuan W, Matsumoto T, Takahashi T.

Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

Eur J Haematol 108(3):212-222,2022.  doi: 10.1111/ejh.13728.

https://pubmed.ncbi.nlm.nih.gov/34862665/

Zhao T, Wang Z, Fang J, Chengc W, Zhang Y, Huang J, Xu L, Zeng L, Jin Z, and Matsuoka M.

HTLV-1 activates YAP by NF-κB/p65 to promote oncogenesis.

Proc Natl Acad Sci USA  119(9):e2115316119,2022. doi: 10.1073/pnas.2115316119.

https://pubmed.ncbi.nlm.nih.gov/35210364/

Shichijo T, Tatetsu H, Nosaka K, Higuchi Y, Kikukawa Y, Inoue Y, Toyoda K, Yasunaga JI, Matsuoka M.

Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

eJHaem 1–9,2022.

https://onlinelibrary.wiley.com/doi/10.1002/jha2.393

Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022.  doi: 10.1016/j.jtct.2021.10.021.

https://pubmed.ncbi.nlm.nih.gov/34774818/

Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022. doi: 10.1016/j.jtct.2021.10.021

https://pubmed.ncbi.nlm.nih.gov/34774818/